Dear Users,

The journal ratings for Impact Factor 2024 have been published.

https://jcr.clarivate.com

Kellermann Mónika

Name: Kellermann Mónika

Other profiles: MTMT

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

1998-2018

2018

Kellermann, M., Berecz, R., Bereczki, D.: Does the severity of depressive symptoms after stroke affect long-term survival? An 18-year follow-up.
PLoS One. 13 (12), 1-11, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

2015

Philipsen, A., Jans, T., Graf, E., Matthies, S., Borel, P., Colla, M., Gentschow, L., Langner, D., Jacob, C., Groß, L. S., Sobanski, E., Alm, B., Schumacher-Stien, M., Roesler, M., Retz, W., Retz-Junginger, P., Kis, B., Abdel-Hamid, M., Heinrich, V., Huss, M., Kornmann, C., Bürger, A., Perlov, E., Ihorst, G., Schlander, M., Berger, M., Tebartz van Elst, L., Kellermann, M., Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium: Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: a Randomized Clinical Trial.
JAMA Psychiatry. 72 (12), 1199-, 2015.

doi DEA

2014

Kellermann, M., Bereczki, D.: Post-stroke depression.
Orv. hetil. 155 (34), 1335-1343, 2014.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

2012

Jans, T., Graf, E., Jacob, C., Zwanzger, U., Groß, L. S., Matthies, S., Perlov, E., Hennighausen, K., Jung, M., Rösler, M., Kellermann, M., Gontard, A. v., Hänig, S., Sobanski, E., Alm, B., Poustka, L., Bliznak, L., Colla, M., Gentschow, L., Burghardt, R., Salbach-Andrae, H., Becker, K., Holtmann, M., Freitag, C., Warnke, A., Philipsen, A.: A randomized controlled multicentre trial on the treatment for ADHD in mothers and children: enrolment and basic characteristics of the study sample.
Atten Defic Hyperact Disord. 5 (1), 29-40, 2012.

doi DEA

Journal metrics:

Q2 Clinical Psychology

Q2 Medicine (miscellaneous)

Q2 Psychiatry and Mental Health

2006

Bereczki, D., Kellermann, M.: Stroke és depressio.
In: Vascularis Neurológia. Szerk.: Nagy Zoltán, B+V Lap- és Könyvkiadó Kft., Solymár, 395-403, 2006. ISBN: 9637746528

DEA

2002

Berecz, R., LLerena, A., Rubia, A. d. l., Gómez, J., Kellermann, M., Dorado, P., Degrell, I.: Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
Pharmacopsychiatry. 35 (6), 231-234, 2002.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

Q1 Pharmacology (medical)

Q1 Psychiatry and Mental Health

2001

Schulte-Altedorneburg, G., Droste, D. W., Felszeghy, S. B., Kellermann, M., Popa, V., Hegedűs, K., Hegedűs, C., Schmid, M., Módis, L., Ringelstein, E. B., Csiba, L.: Accuracy of in vivo carotid B-mode ultrasound compared with pathological analysis: intima-media thickening, lumen diameter, and cross-sectional area.
Stroke. 32 (7), 1520-1524, 2001.

doi DEA

Journal metrics:

D1 Advanced and Specialized Nursing

D1 Cardiology and Cardiovascular Medicine

D1 Medicine (miscellaneous)

D1 Neurology (clinical)

Q1 Neuroscience (miscellaneous)

Kellermann, M., Gesztelyi, R., Kovács, A., Bereczki, D.: Post-stroke depresszió: irodalmi áttekintés.
Psychiatr Hung. 16 (4), 412-422, 2001.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q4 Psychiatry and Mental Health

2000

Berecz, R., Glaub, T., Kellermann, M., Rubia, A. d. l., LLerena, A., Degrell, I.: Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Pharmacopsychiatry. 33 (1), 42-44, 2000.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

D1 Pharmacology (medical)

Q1 Psychiatry and Mental Health

10.

Schulte-Altedorneburg, G., Droste, D. W., Popa, V., Wohlgemuth, W. A., Kellermann, M., Nabavi, D. G., Csiba, L., Ringelstein, E. B.: Visualization of the basilar artery by transcranial color-coded duplex sonography: comparison with postmortem results.
Stroke. 31 (5), 1123-1127, 2000.

doi DEA

Journal metrics:

D1 Advanced and Specialized Nursing

D1 Cardiology and Cardiovascular Medicine

D1 Medicine (miscellaneous)

D1 Neurology (clinical)

Q1 Neuroscience (miscellaneous)

1999

11.

Gesztelyi, R., Fekete, I., Kellermann, M., Csiba, L., Bereczki, D.: Screening for depressive symptoms among post-stroke outpatients in eastern Hungary.
J. Geriatr. Psychiatry Neurol. 12 (4), 194-199, 1999.

doi DEA

Journal metrics:

Q2 Geriatrics and Gerontology

Q2 Neurology (clinical)

Q2 Psychiatry and Mental Health

12.

Kellermann, M., Fekete, I., Gesztelyi, R., Csiba, L., Kollár, J., Sikula, J., Bereczki, D.: Screening for depressive symptoms in the acute phase of stroke.
Gen. Hosp. Psych. 21 (2), 116-121, 1999.

doi DEA

Journal metrics:

Q1 Psychiatry and Mental Health

1998

13.

Nagy, E., Berecz, R., Kellermann, M., Degrell, I., Nagy, E. T., Dinya, Z.: The measurement of haloperidol and reduced haloperidol in plasma of psychiatric patients and their relationship to the administered.
Advances in chromatography and electrophoresis 1, 151-159, 1998.

14.

Berecz, R., Nagy, E., Kellermann, M., Degrell, I.: The measurement of the plasma levels of risperidone and its metabolite 9-hydroxyrisperidone in psychiatric patients.
Adv. Chrom. Electrop. 1, 19-23, 1998.